This page contains a Flash digital edition of a book.
Advances in Therapeutic Options for Gait and Balance in Parkinson’s Disease Conclusions


Gait disorders and postural instability are common in patients with PD and respond poorly to dopaminergic agents effective for other features of PD. Gait and balance impairments in PD probably result from an intricate interplay of multisystem degenerations and neurotransmitter deficiencies extending beyond loss of dopaminergic nigral neurons. We showed recently that cholinergic denervation, especially of the thalamus, rather than the degree of nigrostriatal dopaminergic denervation, is associated with falls in PD. Our results are consistent with a key role for the PPN in the maintenance of balance in humans and with PPN dysfunction/degeneration as a cause of impaired postural control and gait in PD. Other recent evidence suggests that PPN degeneration is associated with akinesia, including gait ignition failure and gait freezing, in PD. Degeneration of cholinergic corticopetal afferents from the basal forebrain complex may play in a role in executive function and attentional deficits contributing to gait and balance dysfunction in PD. Although


1. Quinn N, Parkinsonism-recognition and differential diagnosis, BMJ, 1995;310:447–52.


2. 3. 4.


Factor SA, The clinical spectrum of freezing of gait in atypical parkinsonism, Mov Disord, 2008;23(Suppl. 2):S431–8.


Hughes AJ, Daniel SE, Blankson S, Lees AJ, A clinicopathologic study of 100 cases of Parkinson’s disease, Arch Neurol, 1993;50:140–8.


Bernheimer H, Birkmayer W, Hornykiewicz O, et al., Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations, J Neurol Sci, 1973;20:415–55.


5. 6.


Post B, Merkus MP, de Haan RJ, Speelman JD, Prognostic factors for the progression of Parkinson’s disease: a systematic review, Mov Disord, 2007;22:1839–51; quiz 1988.


Azulay JP, Van Den Brand C, Mestre D, et al., [Automatic motion analysis of gait in patients with Parkinson disease: effects of levodopa and visual stimulations], Rev Neurol (Paris), 1996;152:128–34. Article in French.


7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19. 20.


Kemoun G, Defebvre L, [Clinical description, analysis of posture, initiation of stabilized gait], Presse Med, 2001;30:452–9. Article in French.


Murray MP, Sepic SB, Gardner GM, Downs WJ, Walking patterns of men with parkinsonism, Am J Phys Med, 1978;57:278–94.


Nieuwboer A, Dom R, De Weerdt W, et al., Abnormalities of the spatiotemporal characteristics of gait at the onset of freezing in Parkinson’s disease, Mov Disord, 2001;16:1066–75.


Bloem BR, Grimbergen YA, Cramer M, et al., Prospective assessment of falls in Parkinson’s disease, J Neurol, 2001;248:950–8.


Morris ME, Movement disorders in people with Parkinson disease: a model for physical therapy, Phys Ther, 2000;80:578–97.


Bloem BR, Grimbergen YAM, Cramer M, et al., Prospective assessment of falls in Parkinson’s disease, Mov Disord, 1998;10:147.


Pickering RM, Mazibrada G, Wood BH, et al., A meta-analysis of six prospective studies of falls in Parkinson’s disease, Mov Disord, 2004;19:S262.


Bloem BR, van Vugt JP, Beckley DJ, Postural instability and falls in Parkinson’s disease, Adv Neurol, 2001;87:209–23.


Wood BH, Bilclough JA, Bowron A, Walker RW, Incidence and prediction of falls in Parkinson’s disease: a prospective multidisciplinary study, J Neurol Neurosurg Psychiatry, 2002;72:721–5.


Gray P, Hildebrand K, Fall risk factors in Parkinson’s disease, J Neurosci Nurs, 2000;32:222–8.


Bohnen NI, Cham R, Postural control, gait, and dopamine functions in parkinsonian movement disorders, Clin Geriatr Med, 2006;22:797–812.


Bowes SG, Clark PK, Leeman AL, et al., Determinants of gait in the elderly parkinsonian on maintenance levodopa/carbidopa therapy, Br J Clin Pharmacology, 1990;30:13–24.


Ferrandez AM, Blin O, A comparison between the effect of intentional modulations and the action of L-dopa on gait in Parkinson’s disease, Behav Brain Res, 1991;45:177–83.


O’Sullivan JD, Said CM, Dillon LC, et al., Gait analysis in patients with Parkinson’s disease and motor fluctuations: influence of levodopa and comparison with other measures of motor function, Mov Disord, 1998;13:900–6.


21. 22. 23.


Shan DE, Lee SJ, Chao LY, Yeh SI, Gait analysis in advanced Parkinson’s disease—effect of levodopa and tolcapone, Can J Neurol Sci, 2001;28:70–5.


Blin O, Ferrandez AM, Pailhous J, Serratrice G, Dopa-sensitive and dopa-resistant gait parameters in Parkinson’s disease, J Neurol Sci, 1991;103:51–4.


Ebersbach G, Heijmenberg M, Kindermann L, et al., Interference 24. 25.


STN DBS in PD patients produces sustained benefits for tremor and bradykinesia, axial motor function continues to decline. Low-frequency DBS of the PPN is emerging as a treatment for postural and gait disorders in PD, although the PPN is a technically challenging target. New lines of research are emerging exploring non-dopaminergic pharmacologic treatments of gait and balance problems in PD. Cholinergic therapies may benefit frequently falling PD patients. Contrary to open-label experiences, a recent placebo-controlled study did not find gait improvements with methylphenidate therapy in PD. Non-pharmacologic and non-surgical approaches to treating mobility problems in PD emphasize the increasing importance of exercise and physical fitness in PD. As comorbid white matter disease is associated with impaired axial symptoms and increased stooped posture in PD, it is possible that aggressive management of vascular or inflammatory risk factors, especially when initiated early in the disease course, could reduce the severity of axial motor dysfunction in PD. n


of rhythmic constraint on gait in healthy subjects and patients with early Parkinson’s disease: evidence for impaired locomotor pattern generation in early Parkinson’s disease., Mov Disord, 1999;14:619–25.


Rossignol S, Dubuc R, Gossard JP, Dynamic sensorimotor interactions in locomotion, Physiol Rev, 2006;86:89–154.


Mori S, Matsui T, Kuze B, et al., Stimulation of a restricted region in the midline cerebellar white matter evokes coordinated quadrupedal locomotion in the decerebrate cat, J Neurophysiol, 1999;82:290–300.


26. 27. 28. 29. 30. 31. 32. 33. 34. 35. 36. 37. 38. 39. 40. 41. 42. 43. 44. 45.


Shik ML, Orlovsky GN, Neurophysiology of locomotor automatism, Physiol Rev, 1976;56:465–501.


Alexander GE, DeLong MR, Strick PL, Parallel organization of functionally segregated circuits linking basal ganglia and cortex, Annu Rev Neurosci, 1986;9:357–81.


Redgrave P, Rodriguez M, Smith Y, et al., Goal-directed and habitual control in the basal ganglia: implications for Parkinson’s disease, Nat Rev Neurosci, 2010;11:760–72.


Balleine BW, O’Doherty JP, Human and rodent homologies in action control: corticostriatal determinants of goal-directed and habitual action, Neuropsychopharmacology, 2010;35:48–69.


Yin HH, Knowlton BJ, The role of the basal ganglia in habit formation, Nat Rev Neurosci, 2006;7:464–76.


Latt LD, Sparto PJ, Furman JM, Redfern MS, The steady-state postural response to continuous sinusoidal galvanic vestibular stimulation, Gait Posture, 2003;18:64–72.


Horak FB, Shupert CL, Dietz V, Horstmann G, Vestibular and somatosensory contributions to responses to head and body displacements in stance, Exp Brain Res, 1994;100:93–106.


Mahboobin A, Loughlin PJ, Redfern MS, Sparto PJ, Sensory re-weighting in human postural control during moving-scene perturbations, Exp Brain Res, 2005;167:260–7.


Visser JE, Bloem BR, Role of the basal ganglia in balance control, Neural Plast, 2005;12:161–74.


Burleigh-Jacobs A, Horak FB, Nutt JG, Obeso JA, Step initiation in Parkinson’s disease: influence of levodopa and external sensory triggers, Mov Disord, 1997;12:206–15.


Giladi N, Treves TA, Simon ES, et al., Freezing of gait in patients with advanced Parkinson’s disease, J Neural Transm, 2001;108:53–61.


Snijders AH, Toni I, Ruzicka E, Bloem BR, Bicycling breaks the ice for freezers of gait, Mov Disord, 2011;26:367–71.


Kish SJ, Shannak K, Hornykiewicz O, Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson’s disease, N Engl J Med, 1988;318:876–80.


Ouchi Y, Kanno T, Okada H, et al., Changes in dopamine availability in the nigrostriatal and mesocortical dopaminergic systems by gait in Parkinson’s disease, Brain, 2001;124:784–92.


Bartels AL, de Jong BM, Giladi N, et al., Striatal dopa and glucose metabolism in PD patients with freezing of gait, Mov Disord, 2006;21:1326–32.


Azulay JP, Mesure S, Amblard B, et al., Visual control of locomotion in Parkinson’s disease, Brain, 1999;122:111–20.


Lewis GN, Byblow WD, Walt SE, Stride length regulation in Parkinson’s disease: the use of extrinsic, visual cues, Brain, 2000;123:2077–90.


McIntosh GC, Brown SH, Rice RR, Thaut MH, Rhythmic auditory- motor facilitation of gait patterns in patients with Parkinson’s disease, J Neurol Neurosurg Psychiatry, 1997;62:22–6.


Thaut MH, McIntosh GC, Rice RR, et al., Rhythmic auditory stimulation in gait training for Parkinson’s disease patients, Mov Dis, 1996;11:193–200.


Howe TE, Lovgreen B, Cody FW, et al., Auditory cues can modify the gait of persons with early-stage Parkinson’s disease:


64. 65. 66. 67. 60. 61. 62. 63. 54. 55. 56. 57. 58.


a method for enhancing parkinsonian walking performance?, Clin Rehabilitation, 2003;17:363–7.


46. 47. 48. 49. 50. 51. 52. 53.


Woollacott M, Shumway-Cook A, Attention and the control of posture and gait: a review of an emerging area of research, Gait Posture, 2002;16:1–14.


Lundin-Olsson L, Nyberg L, Gustafson Y, ‘Stops walking when talking’ as a predictor of falls in elderly people, Lancet, 1997;349:617.


Lees AJ, Smith E, Cognitive deficits in the early stages of Parkinson’s disease, Brain, 1983;106:257–70.


Dubois B, Pillon B, Cognitive deficits in Parkinson’s disease, J Neurology, 1997;244:2–8.


Stuss DT, Alexander MP, Executive functions and the frontal lobes: a conceptual view, Psychological Res, 2000;63:289–98.


Bloem BR, Valkenburg VV, Slabbekoorn M, van Dijk JG, The multiple tasks test. Strategies in Parkinson’s disease, Exp Brain Res, 2001;137:478–86.


Yogev G, Giladi N, Peretz C, et al., Dual tasking, gait rhythmicity, and Parkinson’s disease: which aspects of gait are attention demanding?, Eur J Neurosci, 2005;22:1248–56.


Marchese R, Bove M, Abbruzzese G, Effect of cognitive and motor tasks on postural stability in Parkinson’s disease: a posturographic study, Mov Disord, 2003;18:652–8.


Camicioli R, Oken BS, Sexton G, et al., Verbal fluency task affects gait in Parkinson’s disease with motor freezing, J Geriatr Psychiatry Neurology, 1998;11:181–5.


Bond JM, Morris M, Goal-directed secondary motor tasks: their effects on gait in subjects with Parkinson disease, Arch Phys Med Rehabilitation, 2000;81:110–6.


O’Shea S, Morris ME, Iansek R, Dual task interference during gait in people with Parkinson disease: effects of motor versus cognitive secondary tasks, Phys Ther, 2002;82:888–97.


Hausdorff JM, Schaafsma JD, Balash Y, et al., Impaired regulation of stride variability in Parkinson’s disease subjects with freezing of gait, Exp Brain Res, 2003;149:187–94.


Hausdorff JM, Cudkowicz ME, Firtion R, et al., Gait variability and basal ganglia disorders: stride-to-stride variations of gait cycle timing in Parkinson’s disease and Huntington’s disease, Mov Disord, 1998;13:428–37.


59.


Springer S, Giladi N, Peretz C, et al., Dual-tasking effects on gait variability: the role of aging, falls, and executive function, Mov Disord, 2006;21:950–7.


Hausdorff JM, Balash J, Giladi N, Effects of cognitive challenge on gait variability in patients with Parkinson’s disease, J Geriatr Psychiatry Neurology, 2003;16:53–8.


Jellinger K, The pedunculopontine nucleus in Parkinson’s disease, progressive supranuclear palsy and Alzheimer’s disease, J Neurol Neurosurg Psychiatry, 1988;51:540–3.


Braak H, Del Tredici K, Nervous system pathology in sporadic Parkinson disease, Neurology, 2008;70:1916–25.


Hirsch EC, Graybiel AM, Duyckaerts C, Javoy-Agid F, Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson disease and in progressive supranuclear palsy, Proc Natl Acad Sci U S A, 1987;84:5976–80.


Lee MS, Rinne JO, Marsden CD, The pedunculopontine nucleus: its role in the genesis of movement disorders, Yonsei Med J, 2000;41:167–84.


Stein JF, Akinesia, motor oscillations and the pedunculopontine nucleus in rats and men, Exp Neurol, 2009;215:1–4.


Pahapill PA, Lozano AM, The pedunculopontine nucleus and Parkinson’s disease, Brain, 2000;123:1767–83.


Alam M, Schwabe K, Krauss JK, The pedunculopontine nucleus area: critical evaluation of interspecies differences relevant for its use as a target for deep brain stimulation, Brain,


US NEUROLOGY 107


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108